" Despite the new hypertension treatment guidelines post SPRINT, new dilemmas persist in day-to-day service, regarding what the best reliable BP measure is, how to confront with BP control in extreme weather, how to manage fragile BP in coarctation aorto-pathy in adults, and how to for transcatheter intervention of drug refractory hypertension. Breakthrough in solving the clinical dilemmas is emerging as well. "
APSC Cloud Forum webinar entitled New Dilemmas and Breakthrough in Hypertension Treatment ( Part II ) 7th Oct 2020
The agenda details are as follows:
Opening & Chairperson-1
David KL Quek, MD; Secretary General of Asian Pacific Society of Cardiology, Consultant Cardiologist, Pantai Hospital Kuala Lumpur, Kuala Lumpur, Malaysia
Speaker-1
Hao-Min Cheng, MD, PhD; A/Prof, Ntl Yang-Ming University, Staff Cardiologist, Taipei Veterans General Hospital, Taipei, Taiwan
Topic: Home BP, Office BP, Ambulatory BP and Central BP: Are They Equal in Guiding Hypertension Treatment ?
Speaker-2
Sazzli Kasim, MD; Professor & Director, UiTM Teaching Hospital, Puncak Alam, Malaysia
Topic: Treatment Strategy for Hypertension in Extreme Weather.
Q&A
Chairperson-2
Chen-Huan Chen, MD, PhD; Professor & Dean, Ntl Yang-Ming University, Taipei, Taiwan
Speaker-3
Masood Sadiq, MD; Professor & Dean, The Institute of Child Health & Children Hospital, Lahore, Pakistan
Topic: Treatment Strategy for Hypertension in Coarctation Aortopathy in Adults.
Speaker-4
Chin Chee Tang, MD; Clinical A/Prof, DUKE-NUS Medical School, Senior Consultant, Dept of Cardiology, National Heart Center Singapore, Singapore
Topic: Interventional Strategy for Treatment of Drug Refractory Hypertension.
Q&A
Closing
Chen-Huan Chen, MD, PhD; Professor & Dean, Ntl Yang-Ming University, Taipei, Taiwan
![](https://s2.save4k.ru/pic/d55UQDDyUdI/mqdefault.jpg)